Cite
Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism.
MLA
Angusti, T., et al. “Thyroid Cancer Prevalence after Radioiodine Treatment of Hyperthyroidism.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 41, no. 6, June 2000, pp. 1006–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10855625&authtype=sso&custid=ns315887.
APA
Angusti, T., Codegone, A., Pellerito, R., & Favero, A. (2000). Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 41(6), 1006–1009.
Chicago
Angusti, T, A Codegone, R Pellerito, and A Favero. 2000. “Thyroid Cancer Prevalence after Radioiodine Treatment of Hyperthyroidism.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 41 (6): 1006–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10855625&authtype=sso&custid=ns315887.